|
Volumn 34, Issue 5, 2012, Pages 686-688
|
Erratum: A venlafaxine and mirtazapine-induced serotonin syndrome confirmed by de- and re-challenge (International Journal of Clinical Pharmacy DOI:10.1007/s11096-012-9666-7);A venlafaxine and mirtazapine-induced serotonin syndrome confirmed by de- and re-challenge
|
Author keywords
Advers drug reaction; Mirtazapine; Rechallenge; Serotonin syndrome; Venlafaxine
|
Indexed keywords
AMOXICILLIN PLUS CLAVULANIC ACID;
CREATINE KINASE;
LORAZEPAM;
MIRTAZAPINE;
NICARDIPINE;
TEMOCILLIN;
VALPROIC ACID;
VENLAFAXINE;
AEROCOCCUS;
AGED;
ARTICLE;
CASE REPORT;
CREATINE KINASE BLOOD LEVEL;
DEPRESSION;
DISEASE SEVERITY;
DRUG SUBSTITUTION;
DRUG URINE LEVEL;
DRUG WITHDRAWAL;
EPILEPSY;
ESCHERICHIA COLI;
FEMALE;
GENERAL CONDITION DETERIORATION;
HOSPITAL ADMISSION;
HOSPITAL READMISSION;
HUMAN;
HYPERHIDROSIS;
HYPERREFLEXIA;
HYPERTENSION;
METABOLIC ENCEPHALOPATHY;
MYDRIASIS;
PRIORITY JOURNAL;
PROVOCATION TEST;
RESTLESSNESS;
SEROTONIN SYNDROME;
TACHYCARDIA;
UNCONSCIOUSNESS;
URINALYSIS;
URINARY TRACT INFECTION;
|
EID: 84867402965
PISSN: 22107703
EISSN: None
Source Type: Journal
DOI: 10.1007/s11096-012-9689-0 Document Type: Erratum |
Times cited : (12)
|
References (10)
|